Time to Achieve a Prostate Specific Antigen Nadir of 0.2 Ng./ml. After Simultaneous Irradiation For Prostate Cancer
- 1 December 2002
- journal article
- Published by Wolters Kluwer Health in Journal of Urology
- Vol. 168 (6) , 2434-2438
- https://doi.org/10.1016/s0022-5347(05)64162-6
Abstract
No abstract availableKeywords
This publication has 7 references indexed in Scilit:
- A STANDARD DEFINITION OF DISEASE FREEDOM IS NEEDED FOR PROSTATE CANCER: UNDETECTABLE PROSTATE SPECIFIC ANTIGEN COMPARED WITH THE AMERICAN SOCIETY OF THERAPEUTIC RADIOLOGY AND ONCOLOGY CONSENSUS DEFINITIONJournal of Urology, 2002
- 10-year biochemical (prostate-specific antigen) control of prostate cancer with 125I brachytherapyInternational Journal of Radiation Oncology*Biology*Physics, 2001
- Patterns and fate of PSA bouncing following 3D-CRTInternational Journal of Radiation Oncology*Biology*Physics, 2001
- DEFINING PROSTATE SPECIFIC ANTIGEN PROGRESSION AFTER RADICAL PROSTATECTOMY: WHAT IS THE MOST APPROPRIATE CUT POINT?Journal of Urology, 2001
- The correlation of serial prostate specific antigen measurements with clinical outcome after external beam radiation therapy of patients for prostate carcinomaCancer, 2000
- PROSTATE SPECIFIC ANTIGEN BOUNCE AFTER RADIOACTIVE SEED IMPLANTATION FOLLOWED BY EXTERNAL BEAM RADIATION FOR PROSTATE CANCERJournal of Urology, 2000
- Prostate Specific Antigen in the Preoperative and Postoperative Evaluation of Localized Prostatic Cancer Treated with Radical ProstatectomyJournal of Urology, 1988